Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 131 results.
User Information
Export Records
  1. 1.   Aberrant CD8+T cells drive reproductive dysfunction in female mice with elevated IFN-gamma levels
  2. Bafor, Enitome E; Erwin-Cohen, Rebecca A; Martin, Toni; Baker, Clayton; Kimmel, Adrienne E; Duverger, Olivier; Fenimore, John M; Ramba, Meredith; Spindel, Thea; Hess, Megan M; Sanford, Michael; Lazarevic, Vanja; Benayoun, Bérénice A; Young, Howard A; Valencia, Julio C
  3. Frontiers in Immunology. 2024, Apr 18; 15: 1368572.
  1. 2.   Effect of Calcium Carbonate Encapsulation on the Activity of Orally Administered CpG Oligonucleotides
  2. Kayraklioglu, Neslihan; Scheiermann, Julia; Alvord, W. Gregory; Klinman, Dennis
  3. MOLECULAR THERAPY-NUCLEIC ACIDS. 2017, Sep 15; 8: 243-249.
  1. 3.   Suppressed Type 1, Type 2, and Type 17 Cytokine Responses in Active Tuberculosis in Children
  2. Kumar, N. P.; Anuradha, R.; Suresh, R.; Ganesh, R.; Shankar, J.; Kumaraswami, V.; Nutman, T. B.; Babu, S.
  3. Clinical and Vaccine Immunology. 2011, Nov; 18(11): 1856-1864.
  1. 4.   Secretoglobin 3A2 Suppresses Bleomycin-induced Pulmonary Fibrosis by Transforming Growth Factor beta Signaling Down-regulation
  2. Kurotani, R.; Okumura, S.; Matsubara, T.; Yokoyama, U.; Buckley, J. R.; Tomita, T.; Kezuka, K.; Nagano, T.; Esposito, D.; Taylor, T. E.; Gillette, W. K.; Ishikawa, Y.; Abe, H.; Ward, J. M.; Kimura, S.
  3. Journal of Biological Chemistry. 2011, Jun; 286(22): 19682-19692.
  1. 5.   Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
  2. Buhtoiarov, I. N.; Sondel, P. M.; Wigginton, J. M.; Buhtoiarova, T. N.; Yanke, E. M.; Mahvi, D. A.; Rakhmilevich, A. L.
  3. Immunology. 2011, Feb; 132(2): 226-239.
  1. 6.   Cloning of guinea pig IL-4: Reduced IL-4 mRNA after vaccination or Mycobacterium tuberculosis infection
  2. Jeevan, A.; Yoshimura, T.; Ly, L. H.; Dirisala, V. R.; McMurray, D. N.
  3. Tuberculosis. 2011, Jan; 91(1): 47-56.
  1. 7.   Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
  2. Libutti, S. K.; Paciotti, G. F.; Byrnes, A. A.; Alexander, H. R.; Gannon, W. E.; Walker, M.; Seidel, G. D.; Yuldasheva, N.; Tamarkin, L.
  3. Clinical Cancer Research. 2010, Dec; 16(24): 6139-6149.
  1. 8.   Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease
  2. Kuhns, D. B.; Alvord, W. G.; Heller, T.; Feld, J. J.; Pike, K. M.; Marciano, B. E.; Uzel, G.; DeRavin, S. S.; Priel, D. A. L.; Soule, B. P.; Zarember, K. A.; Malech, H. L.; Holland, S. M.; Gallin, J. I.
  3. New England Journal of Medicine. 2010, Dec; 363(27): 2600-2610.
  1. 9.   STAT1 activation regulates proliferation and differentiation of renal progenitors
  2. Wang, H.; Yang, Y.; Sharma, N.; Tarasova, N. I.; Timofeeva, O. A.; Winkler-Pickett, R. T.; Tanigawa, S.; Perantoni, A. O.
  3. Cellular Signalling. 2010, Nov; 22(11): 1717-1726.
  1. 10.   Interleukin-26: An IL-10-related cytokine produced by Th17 cells
  2. Donnelly, R. P.; Sheikh, F.; Dickensheets, H.; Savan, R.; Young, H. A.; Walter, M. R.
  3. Cytokine & Growth Factor Reviews. 2010, Oct; 21(5): 393-401.
  1. 11.   Tumor-Specific CD8(+) T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
  2. Kerkar, S. P.; Muranski, P.; Kaiser, A.; Boni, A.; Sanchez-Perez, L.; Yu, Z. Y.; Palmer, D. C.; Reger, R. N.; Borman, Z. A.; Zhang, L.; Morgan, R. A.; Gattinoni, L.; Rosenberg, S. A.; Trinchieri, G.; Restifo, N. P.
  3. Cancer Research. 2010, Sep; 70(17): 6725-6734.
  1. 12.   Kinetics of Serum Cytokines after Primary or Repeat Vaccination with the Smallpox Vaccine
  2. Cohen, J. I.; Hohman, P.; Fulton, R.; Turk, S. P.; Qin, J.; Thatcher, K.; Hornung, R. L.
  3. Journal of Infectious Diseases. 2010, Apr; 201(8): 1183-1191.
  1. 13.   Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants
  2. Klinman, D. M.; Klaschik, S.; Tomaru, K.; Shirota, H.; Tross, D.; Ikeuchi, H.
  3. Vaccine. 2010, Feb; 28(8): 1919-1923.
  1. 14.   Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia
  2. Vinh, D. C.; Patel, S. Y.; Uzel, G.; Anderson, V. L.; Freeman, A. F.; Olivier, K. N.; Spalding, C.; Hughes, S.; Pittaluga, S.; Raffeld, M.; Sorbara, L. R.; Elloumi, H. Z.; Kuhns, D. B.; Turner, M. L.; Cowen, E. W.; Fink, D.; Long-Priel, D.; Hsu, A. P.; Ding, L.; Paulson, M. L.; Whitney, A. R.; Sampaio, E. P.; Frucht, D. M.; Deleo, F. R.; Holland, S. M.
  3. Blood. 2010, Feb; 115(8): 1519-1529.
  1. 15.   Regulatory T Cells Modulate Th17 Responses in Patients with Positive Tuberculin Skin Test Results
  2. Babu, S.; Bhat, S. Q.; Kumar, N. P.; Kumaraswami, V.; Nutman, T. B.
  3. Journal of Infectious Diseases. 2010, Jan; 201(1): 20-31.
  1. 16.   Coexpression of IL-18 Strongly Attenuates IL-12-Induced Systemic Toxicity through a Rapid Induction of IL-10 without Affecting its Antitumor Capacity
  2. Rodriguez-Galan, M. C.; Reynolds, D.; Correa, S. G.; Iribarren, P.; Watanabe, M.; Young, H. A.
  3. Journal of Immunology. 2009, Jul; 183(1): 740-748.
  1. 17.   Attenuation of Toll-Like Receptor Expression and Function in Latent Tuberculosis by Coexistent Filarial Infection with Restoration Following Antifilarial Chemotherapy
  2. Babu, S.; Bhat, S. Q.; Kumar, N. P.; Anuradha, R.; Kumaran, P.; Gopi, P. G.; Kolappan, C.; Kumaraswami, V.; Nutman, T. B.
  3. Plos Neglected Tropical Diseases. 2009 3(7): 1, e489-7, e489.
  1. 18.   Bone marrow deficient in IFN-gamma signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect
  2. Capitini, C. M.; Herby, S.; Milliron, M.; Anver, M. R.; Mackall, C. L.; Fry, T. J.
  3. Blood. 2009 113(20): 5002-5009.
  1. 19.   Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment
  2. Weiss, J. M.; Back, T. C.; Scarzello, A. J.; Subleski, J. J.; Hall, V. L.; Stauffer, J. K.; Chen, X.; Micic, D.; Alderson, K.; Murphy, W. J.; Wiltrout, R. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(46): 19455-19460.
  1. 20.   Clinical Use of Interferon-gamma
  2. Miller, C. H. T.; Maher, S. G.; Young, H. A.; Donnelly, R. P.
  3. Cytokine Therapies: Novel Approaches for Clinical Indications. 2009; 1182 : 69-79.
  1. 21.   An Overview of Cytokines and Cytokine Antagonists as Therapeutic Agents
  2. Donnelly, R. P.; Young, H. A.; Rosenberg, A. S.; Donnelly, R. P.
  3. Cytokine Therapies: Novel Approaches for Clinical Indications. 2009; 1182 : 1-13.
  1. 22.   Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells
  2. Gerosa, F.; Baldani-Guerra, B.; Lyakh, L. A.; Batoni, G.; Esin, S.; Winkler-Pickett, R. T.; Consolaro, M. R.; De Marchi, M.; Giachino, D.; Robbiano, A.; Astegiano, M.; Sambataro, A.; Kastelein, R. A.; Carra, G.; Trinchieri, G.
  3. Journal of Experimental Medicine. 2008 205(6): 1447-1461.
  1. 23.   Suppressive oligodeoxynucleotides inhibit silica-induced pulmonary inflammation
  2. Sato, T.; Shimosato, T.; Alvord, W. G.; Klinman, D. M.
  3. Journal of Immunology. 2008 180(11): 7648-7654.
  1. 24.   Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation
  2. Sun, K.; Li, M. H.; Sayers, T. J.; Welniak, L. A.; Murphy, W. J.
  3. Blood. 2008 112(4): 1522-1529.
  1. 25.   Effect of CpG oligonucleotides on vaccine-induced B cell memory
  2. Tross, D.; Klinman, D. M.
  3. Journal of Immunology. 2008 181(8): 5785-5790.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel